Efficacy of the CMI Magnetocardiograph in Diagnosing Acute Coronary Syndromes in Patients Presenting With High Risk Unstable Angina.
1 other identifier
observational
137
1 country
1
Brief Summary
A magnetocardiograph (MCG) is a device capable of recording of magnetic fields arising from the electrical activity of the heart with traces similar to an electrocardiogram (ECG). This system was developed as a noninvasive, non-contact diagnostics of obstructive coronary artery disease (CAD), and especially of lack of oxygen in the heart as in a heart attack. The overall objective of this study is to demonstrate the efficacy of this MCG device for the detection and diagnosis of lack of oxygen of the heart in patients with chest pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2004
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2004
CompletedFirst Submitted
Initial submission to the registry
September 12, 2005
CompletedFirst Posted
Study publicly available on registry
September 15, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2008
CompletedJuly 18, 2011
July 1, 2011
3.5 years
September 12, 2005
July 15, 2011
Conditions
Outcome Measures
Primary Outcomes (2)
1. Determine the discriminatory ability of the scores derived from the MCG evaluation to discriminate between patients with versus without a clinical diagnosis of ACS at discharge.
1 year
2. Compare the discriminatory ability of scores derived from the MCG, the troponin level, and the ECG results, separately or in combination, to discriminate between patients with without a diagnosis of ACS at discharge.
1 year
Secondary Outcomes (1)
1. Evaluate the sensitivity of the MCG to detect an ultimate diagnosis of ACS, MI, CHF, or death at 1 month, 6 months, and 1 year following discharge.
1 year
Interventions
MCG and ECG recordings sequentially at the four pre-defined bed positions and watches the real-time magnetocardiogram traces on the computer screen. At each position, nine sensors record MCG data, thus forming a 3 x 3 point grid square with point-to-point separation of 40 mm. The number of cardiac cycles recorded at each position should be adequate for signal averaging. Recording time per position is typically 90 seconds. At the end of 4 sequential recordings, raw, unfiltered MCG data are stored.
Eligibility Criteria
\*ACC/AHA Guidelines for Unstable Angina: High Risk (≥1 of the following) History * Accelerating tempo of ischemic symptoms in the last 48 hrs Pain * Prolonged, ongoing (\>20 min) rest pain (resistant to treatment) Clinical findings * Pulmonary edema * New / ↑ MR murmur * S3 or new/ ↑ rales * Hypotension, brady -/tachycardia - Age\>75y ECG * Angina at rest with transient ST changes \>0.05 mV * New (L)BBB * Sustained VT Cardiac Markers * Markedly elevated troponin Patients classified as having high-risk unstable angina at presentation in the ED will be approached for enrollment in the study.
You may qualify if:
- Patients classified as having High Risk Unstable Angina according to the ACCIAHA guidelines.
- Age ≥ 18 years.
You may not qualify if:
- Hemodynamically unstable patients.
- Patients who just prior to or just after admission exhibit tachycardia with heart rates exceeding 150 bpm.
- Patients with third degree AV Block.
- Patients with pacemakers or internal cardiac defibrillators.
- Patients who cannot lie in a supine position for the MCG examination.
- Patients who refuse entry into the registry
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
- CardioMag Imagingcollaborator
Study Sites (1)
Mayo Clinic
Rochester, Minnesota, 55905, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peter A. Smars, M.D. EM
Mayo Clinic
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 12, 2005
First Posted
September 15, 2005
Study Start
August 1, 2004
Primary Completion
February 1, 2008
Study Completion
February 1, 2008
Last Updated
July 18, 2011
Record last verified: 2011-07